Geneseeq Technology Inc., headquartered in Canada, is a pioneering force in the biotechnology industry, specialising in precision medicine and genomic testing. Founded in 2014, the company has rapidly established itself as a leader in the development of innovative solutions for cancer diagnosis and treatment, with a focus on next-generation sequencing (NGS) technologies. With a commitment to enhancing patient outcomes, Geneseeq offers a range of unique products and services, including comprehensive genomic profiling and advanced bioinformatics tools. These offerings empower healthcare professionals to make informed decisions based on precise genetic insights. The company has achieved significant milestones, positioning itself as a trusted partner in the global healthcare landscape, particularly in North America and Asia. Geneseeq's dedication to advancing personalised medicine continues to set it apart in a competitive market.
How does Geneseeq Technology Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Geneseeq Technology Inc.'s score of 26 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Geneseeq Technology Inc., headquartered in Canada, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Geneseeq may not have established formal commitments to reduce its carbon footprint or may be in the early stages of developing such initiatives. In the context of the industry, many companies are increasingly adopting science-based targets and sustainability commitments to address climate change. However, without specific emissions data or reduction initiatives, it is unclear how Geneseeq aligns with these industry standards. As the company progresses, it may consider implementing strategies to measure and reduce its carbon emissions, thereby contributing to broader climate goals.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Geneseeq Technology Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
